Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex
- 1 May 2015
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 112, 72-75
Abstract
No abstract availableKeywords
Funding Information
- Herscot Center for Tuberous Sclerosis Complex
This publication has 11 references indexed in Scilit:
- Development of lacosamide for the treatment of partial‐onset seizuresAnnals of the New York Academy of Sciences, 2013
- Clobazam therapy of refractory epilepsy in tuberous sclerosis complexEpilepsy Research, 2013
- The natural history of epilepsy in tuberous sclerosis complexEpilepsia, 2010
- Infantile spasms: A U.S. consensus reportEpilepsia, 2010
- Intrafamilial Phenotypic Variability in Tuberous Sclerosis ComplexJournal of Child Neurology, 2007
- Tuberous Sclerosis Complex: A ReviewJournal of Pediatric Health Care, 2007
- LacosamideNeurotherapeutics, 2007
- Levetiracetam as Adjunctive Antiepileptic Therapy for Patients with Tuberous Sclerosis Complex: A Retrospective Open-Label TrialJournal of Child Neurology, 2006
- Lamotrigine Therapy of Epilepsy in Tuberous SclerosisEpilepsia, 2001
- Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple OrgansThe American Journal of Human Genetics, 2001